Novel/Potential Therapeutic Drug Targets
|
 |
Novel/Potential Drug Targets (other than vaccines)
2800 drug targets
Orexin 1 receptor, Reptin, JAK3, STAT3, Cyclophilin-CD147 interactions, Trypanothione reductase, p38 and more.
|
|
 |
Novel/Potential Vaccine Targets
Nonsense-mediated messenger RNA decay (NMD), MrkD, Leader sequence of preproinsulin,IL-17, Hsp70L1, S. japonicum
ribosomal protein L7 and more.
|
 |
Disease Targets
Cancer, Alzheimer's disease, acute myeloid leukemia, Type 2 diabetes, Schistosomiasis, Non-small cell lung
cancer and more.
|
Note: Current listings are based on the novel or potential drug targets
that are reported in recent research articles. We update this database on regular basis to include drug targets
from older as well as newer research articles. Please visit this database on regular basis to see these updates.
|
|
|
|
Services offered
SciClips Consultancy
|
| Fostering innovation through scientific intelligence |
Sciclips consultancy service team is comprised of highly qualified and experienced scientists who have several years of research experience in
academic and industrial laboratories. We offer following custom services at competitive price:
Scientific and technical areas covered: Drug discovery, Stem cells, Genomics, Proteomics, Biomarkers, Clinical diagnostics,
Companion diagnostics, Molecular diagnostics, Personalized medicine (theranostics), Plant and agricultural biotechnology
Patent search: Custom intellectual property (IP) analysis; Comprehensive patent database search and evaluation |
Custom data analysis and data mining: From patents, research articles, meeting abstracts and web based information. Custom meta analysis. |
Competitive intelligence analysis: Comprehensive analysis of competitive technologies and products; Technology trend prediction; Identification of technology licensing opportunities; Acquisition target identification; Identification of collaborative technology development opportunities. |
Technology development: Identification of potential development opportunities in drug discovery assay development, cell based assay development, recombinant protein expression (in vitro and in vivo) and mass spectrometry/proteomics reagents and tools; Product development strategy. |
Diagnostics and Theranostics technology development: Diagnostic assay development; Diagnostic target identification (molecular or protein or miRNA or metabolomic biomarkers); Prognostic and drug efficacy biomarkers; Theranostics tools, biomarkers and therapeutic drug targets; Identification of emerging technologies and methods. |
Custom database development |
Customized bioinformatics tools: Offered through our partners. |
Proteomics and Drug discovery services (laboratory based): Offered through our partners. |
For more information on our consultancy services please contact us at contact@sciclips.com
or email us using the contact form
|
|
 |
|
|
Receive news updates by email
|
|
|
Search Potential Drug Targets
|
|
|
Search Potential Disease Targets
|
|
 |
|
|
Keywords:
High Content Screening, Cell Signaling Assays, Methyltransferase Assay, Drug Profiling Service, Pre-Clinical Services, Drug discovery assays, Cell based assays, HTS assays, clinical research services (CRO), GPCR cassays, receptor assays, kinase assays, phosphatase assays, toxicity assays, Reporter Assays,GPCR cell-based assays, Enzyme Inhibitors, screening molecules,Screening Assays,Screening compounds, Small Molecule Screening,Small Molecule Libraries, Raman Spectroscopy,kinase assays, protease assays, caspase assay,apoptosis assays, Receptor Assay, nuclear Receptor Assay,Receptor Binding Assay,Multiplex Assays, calcium assays, Ion Channel Screening, Sodium Channel Screening,HERG channel Assay,genotyping, ATP assay,Glutathione Assay, Genotoxicity assay,Flow Cytometry, Cell Proliferation Assay, Next generation sequencing, contract assay service, High Throughput Screening, Assay development, Drug Discovery Services, Cell based assays, Drug Profiling Service, Compound Profiling, Medicinal chemistry, ion channel assays
|
|
